Abstract:Background and Aim: By Affymatrix SNP6 array screening for copy number variations in gastric cancer (GC), we identified the nuclear protein-coding gene C8orf76 (chromosome 8 open reading frame 76) to be preferentially amplified in primary gastric tumors.However, the role of C8orf76 in human cancer remains unknown.This study aimed to elucidate the biological function, molecular mechanism and clinical significance of C8orf76 in GC.Methods: C8orf76 copy number was quantified by TaqMan qPCR assays.C8orf76 expression was assessed by RT-qPCR and immunohistochemistry. Molecular networks were investigated by RNA sequencing and pathway luciferase reporter assays.Direct downstream genes were elucidated by chromatin immunoprecipitation (ChIP)-sequencing.ChIP-PCR, luciferase reporter and electrophoretic mobility shift assay (EMSA) were performed to detect the binding effect of C8orf76 on candidate DNA motifs.Results: C8orf76 copy number was significantly increased in GC tumors compared to adjacent non-tumor tissues ( P<0.01).Consistently, C8orf76 mRNA and protein were significantly up-regulated in GC tumors compared to adjacent non-tumor tissues (both P<0.001).C8orf76 mRNA expression was positively correlated with its copy number in GC (n=66, R=0.64, P<0.0001), which was validated in TCGA cohort (n=414, R=0.74, P<0.0001).C8orf76 copy gain was significantly associated with advanced TNM stage ( P<0.05).Copy gain and overexpression of C8orf76 were significantly associated with poor prognosis in GC patients (both P<0.05).C8orf76 overexpression in GC cell line (AGS) and normal gastric epithelial cell line (GES1) significantly increased cell viability and clonogenicity, promoted G1-S cell cycle transition, inhibited apoptosis, and enhanced cell migration/invasion abilities (all P<0.05).Conversely, C8orf76 knockdown in GC cells (BGC823 and MKN28) exhibited opposite effects.In addition, MAPK signaling was activated by C8orf76 as identified by RNA sequencing, confirmed by increased SRE reporter activity ( P<0.001) and activation of ERK/2 and p38.The lncRNA DUSP5P1 was identified to be a downstream effector of C8orf76 by ChIP-sequencing and RNA-sequencing.Direct binding of C8orf76 protein to the DNA motif 'AGGCTG' at the promoter region of DUSP5P1 was verified by ChIP-PCR, luciferase reporter assay and EMSA.Expression of DUSP5P1 was positively correlated with C8orf76 levels in GC cells with C8orf76 overexpression or knockdown.Moreover, knockdown of DUSP5P1 could abolish the effects of C8orf76 on cell growth and MAPK activation.Conclusions: C8orf76 is a novel oncogenic factor that is commonly overexpressed in GC due to copy number gain.The tumor promoting effect of C8orf76 in GC was mediated by activating MAPK signaling through directly inducing lncRNA DUSP5P1.C8orf76 copy number and expression serve as potential prognostic biomarkers for GC patients.

C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes.

Su1241 - C8ORF76 Functions As a Novel Oncogene Via Directly Regulating Lncrna DUSP5P1 in Gastric Cancer

Figure S2 from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Figure S3 from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Table S1-S13 from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Figure S1 from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer.

DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance

Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4

HoxC6 Functions As an Oncogene and Isoform HoxC6-2 May Play the Primary Role in Gastric Carcinogenesis

SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK/ERK and PI3K/AKT pathways

The Pseudogene Derived Long Noncoding Rna Duxap8 Promotes Gastric Cancer Cell Proliferation And Migration Via Epigenetically Silencing Plekho1 Expression

LncPSCA in the 8q24.3 risk locus drives gastric cancer through destabilizing DDX5

Enhanced LRP8 Expression Induced by Helicobacter Pylori Drives Gastric Cancer Progression by Facilitating Β-Catenin Nuclear Translocation

C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11

CDK10 Regulates Gastric Cancer Metastasis By Inhibiting lncRNA-C5ORF42-5 Via Phosphorylation Level of AKT/ERK

E2f1-Induced Upregulation Of Long Noncoding Rna Linc00668 Predicts A Poor Prognosis Of Gastric Cancer And Promotes Cell Proliferation Through Epigenetically Silencing Of Ckis

M-phase Phosphoprotein 8 Promotes Gastric Cancer Growth and Metastasis Via P53/bcl-2 and EMT-related Signalling Pathways

KDM6B Promotes Gastric Carcinogenesis and Metastasis Via Upregulation of CXCR4 Expression

LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization

HOXC8 mediates osteopontin expression in gastric cancer cells